What are the main indications for use?

It is indicated for vitamin C deficiency, fever, and chronic wasting disease.

Do you offer OEM and ODM services?

Yes, we provide both OEM and ODM services for our customers.

What payment methods do you accept?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Animals Using 25% Vitamin C Soluble White Powder Feed Additive for Vitamin C Deficiency

Name: Animals Using 25% Vitamin C Soluble White Powder Feed Additive for Vitamin C Deficiency
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1975415192

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$0.58-0.68

1,000 Bags

Sample price:US$1.00/kg.Request sample

Product profile

Customization

Available

Certification

ISO

Element

Vitamin C

Model NO.

Shape

Powder

Type

The First Class

Formula

Cuatomization

Function

Vitamin Additives

Specification

1kg/bag

Trademark

Moosun

Origin

China

HS Code

2309901000

Production Capacity

500tons/Month

Key features

25% Vitamin C Content: Contains 250mg of Ascorbic Acid per gram for treating deficiency.

Formula Customization: Custom formula options available to meet specific needs.

ISO Certified Quality: Manufactured under ISO certification standards for safety.

Veterinary Application: Specifically designed for treating fever and chronic wasting disease.

Long Shelf Life: Guaranteed 2-year expiry date when stored properly.

OEM/ODM Services: Full OEM and ODM services available for branding needs.

Manufacturer Direct: Direct sales from Muxiang Group with 20 R&D engineers.

Flexible Payment Terms: Accepts LC, T/T, PayPal, and Western Union for transactions.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤10.92h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.